Angiotensin-converting enzyme gene polymorphism is not associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients

Background The deletion (D) allele of the angiotensin‐converting enzyme (ACE) gene has been proposed as a genetic marker of the risk of ischaemic heart disease. However, the relationships between ACE genotypes, the development of coronary atherosclerosis and the occurrence of major coronary events a...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of clinical investigation Vol. 28; no. 6; pp. 485 - 490
Main Authors ARCA, M, PANNITTERI, G, CAMPAGNA, F, CANDELORO, A, MONTALI, A, CANTINI, R, SECCARECCIA, F, CAMPA, P. P, MARINO, B, RICCI, G
Format Journal Article
LanguageEnglish
Published Oxford BSL Blackwell Science Ltd 01.06.1998
Blackwell
Blackwell Publishing Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The deletion (D) allele of the angiotensin‐converting enzyme (ACE) gene has been proposed as a genetic marker of the risk of ischaemic heart disease. However, the relationships between ACE genotypes, the development of coronary atherosclerosis and the occurrence of major coronary events are still controversial. Methods To investigate whether the ACE I/D (insertion/deletion) polymorphism predicts the risk of coronary stenosis and myocardial infarction (MI), ACE genotypes were determined in 394 consecutive patients who underwent coronary angiography. The presence of coronary artery disease (CAD) (defined by > 50% stenosis) was detected in 236 patients (CAD+); 85 of these individuals had a history of MI. Patients with coronary stenosis < 10% (n = 158) served as controls (CAD−). ACE genotypes were determined by agarose gel sizing after polymerase chain reaction (PCR) amplification. Results The distribution of ACE genotypes in CAD+ patients was not significantly different from that in CAD− patients (χ2 = 2.63, P < 0.27). After controlling for other coronary risk factors, no significant increase in risk of CAD or MI was found to be associated with the D allele, regardless of whether the D allele was assumed to have a dominant, a co‐dominant or a recessive effect. Similar results were observed in CAD+ patients at lower risk because of low body mass index and apolipoprotein B concentrations. Smoking, apolipoprotein B and history of hypertension were found to be independent predictors of CAD and MI. Conclusion Our study did not provide evidence of a significant association between ACE genotypes and the development of coronary atherosclerosis. It also failed to support a role of ACE I/D polymorphism in favouring the conversion of coronary stenosis to MI.
Bibliography:ark:/67375/WNG-SJ19976M-B
ArticleID:ECI313
istex:562772EB109996C5E8971317826CFB1DE9F319B2
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-2972
1365-2362
DOI:10.1046/j.1365-2362.1998.00313.x